SS

Shyamla Singh

Active Director Director DIN 08191770
DIN 08191770 First appointment Aug 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Shyamla Singh

Data last updated:

Shyamla Singh is a Director at Chemiva Pharmaceuticals Private Limited (since 2018). The company operates in Business Services. Chemiva Pharmaceuticals Private Limited reported revenue of ₹21.8 Lakh (FY 2025).

DIN 08191770
Primary Designation Director
Industry Business Services
First Appointment 02 Aug 2018
Oldest Company Age 8 yrs
Largest company Chemiva Pharmaceuticals Private Limited · ₹21.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Aug 20182018₹21.8 Lakh (FY 2025)Active

Board colleagues of Shyamla Singh

Directorship timeline

Open interactive timeline →
Chemiva Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shyamla Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyamla Singh

Shyamla Singh currently holds 1 directorship: Chemiva Pharmaceuticals Private Limited (Director, since 02 Aug 2018, revenue ₹21.8 Lakh (FY 2025)).

Shyamla Singh was first appointed on 02 Aug 2018 as Director at Chemiva Pharmaceuticals Private Limited.

The current boards of Shyamla Singh's companies include Hari Om Singh (Chemiva Pharmaceuticals Private Limited), Lakshmi Singh (Chemiva Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available